The Capable ABL: What Is Its Biological Function?

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Molecular and Cellular Biology

• Publication date

  2014-01-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/MCB.01454-13PMID 24421390PMCID PMC3993570
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CSF1R signaling blockade stanches tumor-infiltrating myeloid cells and improves the efficacy of radiotherapy in prostate cancer.

  2013cited by this paper
• Phosphoregulation of the WAVE regulatory complex and signal integration.

  2013cited by this paper
• Membrane and actin dynamics interplay at lamellipodia leading edge.

  2013cited by this paper
• Mitophagy and Parkinson's disease: be eaten to stay healthy.

  2013cited by this paper
• Role of ABL family kinases in cancer: from leukaemia to solid tumours

  2013cited by this paper
• Effect of long term imatinib on bone in adults with chronic myelogenous leukemia and gastrointestinal stromal tumors.

  2013cited by this paper
• Role of Abl in airway hyperresponsiveness and airway remodeling

  2013cited by this paper
• Genetic disruption of Abl nuclear import reduces renal apoptosis in a mouse model of cisplatin-induced nephrotoxicity

  2013cited by this paper
• Abl kinases are required for vascular function, Tie2 expression, and angiopoietin-1–mediated survival

  2013cited by this paper
• c-Abl-dependent Molecular Circuitry Involving Smad5 and Phosphatidylinositol 3-Kinase Regulates Bone Morphogenetic Protein-2-induced Osteogenesis*

  2013cited by this paper
• KAT5 tyrosine phosphorylation couples chromatin sensing to ATM signalling

  2013cited by this paper
• Tyrosine kinase inhibition facilitates autophagic SNCA/α-synuclein clearance

  2013cited by this paper
• Neuroprotective Efficacy of a New Brain-Penetrating C-Abl Inhibitor in a Murine Parkinson’s Disease Model

  2013cited by this paper
• Abl Family Kinases Modulate T Cell–Mediated Inflammation and Chemokine-Induced Migration Through the Adaptor HEF1 and the GTPase Rap1

  2012cited by this paper
• New insights into the regulation and cellular functions of the ARP2/3 complex

  2012cited by this paper
• Puma, a critical mediator of cell death — one decade on from its discovery

  2012cited by this paper
• Posttranslational modifications of the retinoblastoma tumor suppressor protein as determinants of function.

  2012cited by this paper
• CTD Tyrosine Phosphorylation Impairs Termination Factor Recruitment to RNA Polymerase II

  2012cited by this paper
• The role of apoptosis-induced proliferation for regeneration and cancer.

  2012cited by this paper
• Regulation of Neuronal Cell Death by c-Abl-Hippo/MST2 Signaling Pathway

  2012cited by this paper
• c-Abl promotes osteoblast expansion by differentially regulating canonical and non-canonical BMP pathways and p16INK4a expression

  2012cited by this paper
• ABL1 regulates spindle orientation in adherent cells and mammalian skin

  2012cited by this paper
• c-Abl in Neurodegenerative Disease

  2011cited by this paper
• Tip60-mediated acetylation activates transcription independent apoptotic activity of Abl

  2011influential reference
• The nucleoskeleton as a genome-associated dynamic 'network of networks'

  2011cited by this paper
• Interplay between Kinase Domain Autophosphorylation and F-Actin Binding Domain in Regulating Imatinib Sensitivity and Nuclear Import of BCR-ABL

  2011cited by this paper
• An evolutionarily acquired genotoxic response discriminates MyoD from Myf5, and differentially regulates hypaxial and epaxial myogenesis

  2011cited by this paper
• Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function

  2010cited by this paper
• ABL Tyrosine Kinases: Evolution of Function, Regulation, and Specificity

  2010influential reference
• Abl Family Tyrosine Kinases Are Essential for Basement Membrane Integrity and Cortical Lamination in the Cerebellum

  2010influential reference
• Synaptic Clustering of PSD-95 Is Regulated by c-Abl through Tyrosine Phosphorylation

  2010cited by this paper
• Abl tyrosine kinases in T‐cell signaling

  2009cited by this paper
• Translation of the Philadelphia chromosome into therapy for CML.

  2008cited by this paper
• Structural Coupling of SH2-Kinase Domains Links Fes and Abl Substrate Recognition and Kinase Activation

  2008cited by this paper
• The c-Abl tyrosine kinase regulates actin remodeling at the immune synapse.

  2008cited by this paper
• Abl Kinases Regulate Autophagy by Promoting the Trafficking and Function of Lysosomal Components*

  2008cited by this paper
• Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage.

  2008cited by this paper
• Delayed activation of Bax by DNA damage in embryonic stem cells with knock-in mutations of the Abl nuclear localization signals

  2007influential reference
• A Src-Like Inactive Conformation in the Abl Tyrosine Kinase Domain

  2006cited by this paper
• Computational Analysis and Prediction of the Binding Motif and Protein Interacting Partners of the Abl SH3 Domain

  2006cited by this paper
• A kinase-independent function of c-Abl in promoting proteolytic destruction of damaged DNA binding proteins.

  2006cited by this paper
• Abl Tyrosine Kinase Regulates Endocytosis of the Epidermal Growth Factor Receptor*

  2006cited by this paper
• JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of c-Abl in the apoptotic response to DNA damage

  2005cited by this paper
• Structural basis for the cytoskeletal association of Bcr-Abl/c-Abl.

  2005influential reference
• Role of c-Abl in the DNA damage stress response

  2005cited by this paper
• Regulation of the c-Abl and Bcr–Abl tyrosine kinases

  2004influential reference
• Coordination of repair, checkpoint, and cell death responses to DNA damage.

  2004cited by this paper
• Controlling Abl: auto-inhibition and co-inhibition?

  2004cited by this paper
• Enteropathogenic Escherichia coli use redundant tyrosine kinases to form actin pedestals.

  2004cited by this paper
• Structural basis for the autoinhibition of c-Abl tyrosine kinase.

  2003cited by this paper
• A myristoyl/phosphotyrosine switch regulates c-Abl.

  2003cited by this paper
• The CTD code

  2003cited by this paper
• Regulation of F-actin-dependent processes by the Abl family of tyrosine kinases

  2003cited by this paper
• Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR–ABL tyrosine kinase

  2001cited by this paper
• Inhibition of c-Abl Tyrosine Kinase Activity by Filamentous Actin*

  2001influential reference
• c-Abl Has High Intrinsic Tyrosine Kinase Activity That Is Stimulated by Mutation of the Src Homology 3 Domain and by Autophosphorylation at Two Distinct Regulatory Tyrosines*

  2000cited by this paper
• c-Abl Tyrosine Kinase Is Not Essential for Ataxia Telangiectasia Mutated Functions in Chromosomal Maintenance*

  2000cited by this paper
• Crystal structures of c-Src reveal features of its autoinhibitory mechanism.

  1999cited by this paper
• The presence of the Rb c-box peptide in the cytoplasm inhibits p210bcr-abl transforming function

  1999influential reference
• Nuclear-cytoplasmic shuttling of C-ABL tyrosine kinase.

  1998cited by this paper
• Essential roles for the Abl and Arg tyrosine kinases in neurulation.

  1998influential reference
• Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation

  1997influential reference
• Three-dimensional structure of the tyrosine kinase c-Src

  1997cited by this paper
• Activation of the Sire-family tyrosine kinase Hck by SH3 domain displacement

  1997cited by this paper
• Crystal structure of the Src family tyrosine kinase Hck

  1997cited by this paper
• Interaction between ATM protein and c-Abl in response to DNA damage

  1997cited by this paper
• Integrin regulation of c-Abl tyrosine kinase activity and cytoplasmic-nuclear transport.

  1996cited by this paper
• Differential Regulation of Retinoblastoma Protein Function by Specific Cdk Phosphorylation Sites (*)

  1996cited by this paper
• The cytostatic function of c‐Abl is controlled by multiple nuclear localization signals and requires the p53 and Rb tumor suppressor gene products.

  1996cited by this paper
• Binding of A/T-rich DNA by Three High Mobility Group-like Domains in c-Abl Tyrosine Kinase*

  1996cited by this paper
• Coordinate activation of c-Src by SH3- and SH2-binding sites on a novel p130Cas-related protein, Sin.

  1996cited by this paper
• Disruption of retinoblastoma protein function by coexpression of its C pocket fragment.

  1995cited by this paper
• Abi-2, a novel SH3-containing protein interacts with the c-Abl tyrosine kinase and modulates c-Abl transforming activity.

  1995cited by this paper
• Abl-interactor-1, a novel SH3 protein binding to the carboxy-terminal portion of the Abl protein, suppresses v-abl transforming activity.

  1995cited by this paper
• Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites.

  1994influential reference
• A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle.

  1993cited by this paper
• An actin‐binding function contributes to transformation by the Bcr‐Abl oncoprotein of Philadelphia chromosome‐positive human leukemias.

  1993influential reference
• A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins

  1993cited by this paper
• Tyrosine phosphorylation of mammalian RNA polymerase II carboxyl-terminal domain.

  1993cited by this paper
• Identification of a ten-amino acid proline-rich SH3 binding site.

  1993cited by this paper
• Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populations.

  1991cited by this paper
• Activation of tyrosinase kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins

  1991influential reference
• Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene.

  1991cited by this paper
• Three-dimensional structure of the tyrosine kinase cSrc

  year unknowncited by this paper

• Orchestrating Microtubules: A Review of Kinase–Dependent Regulatory Mechanisms

  2026cites this paper
• Comparative In silico evaluation of c-Abl inhibitors for Parkinson's disease therapy.

  2025cites this paper
• The Role of c-Abl in Alzheimer’s Disease: Guilty or not Guilty?

  2025cites this paper
• The Discovery of Abl Kinase ATPase Activity and Its Implications in the Development of Straightforward Assays

  2025cites this paper
• Weighted Ensemble Simulations With the Drude Polarizable Model

  2025cites this paper
• Computational Evaluation of Potential c-Abl Kinase Inhibitors for Parkinson’s Disease: QSAR, Docking, Bioisosteric Replacement, ADMET, and MD Simulations

  2025cites this paper
• NUP214 in Acute Myeloid Leukemia

  2025influential citation
• Haploinsufficiency of ABL1 is associated with dominant isolated omphalocele

  2025influential citation
• Acetylation and Deacetylation of Cytoskeleton-Associated Proteins.

  2025cites this paper
• Analysis of the transcriptional profile of mononuclear cells from e-cigarette users.

  2025cites this paper
• FastConformation: A Standalone ML-Based Toolkit for Modeling and Analyzing Protein Conformational Ensembles at Scale

  2025cites this paper
• BCR-ABL: The molecular mastermind behind chronic myeloid leukemia.

  2025cites this paper
• Predicting Mutation-Induced Relative Protein-Ligand Binding Affinity Changes via Conformational Sampling and Diversity Integration with Subsampled Alphafold2 in Few-Shot Learning

  2025cites this paper
• Prediction of enzyme function using an interpretable optimized ensemble learning framework

  2025cites this paper
• Targeting PI4KB and Src/Abl host kinases as broad-spectrum antiviral strategy: myth or real opportunity?

  2025cites this paper
• Arterio-Occlusive Events Among Patients with Chronic Myeloid Leukemia on Tyrosine Kinase Inhibitors.

  2024cites this paper
• Preliminary identification of somatic mutations profile in ACL injury

  2024cites this paper
• Nested-PCR vs. RT-qPCR: A Sensitivity Comparison in the Detection of Genetic Alterations in Patients with Acute Leukemias

  2024cites this paper
• ABL1-mediated phosphorylation promotes FOXM1-related tumorigenicity by Increasing FOXM1 stability

  2024cites this paper
• Structure‐Guided Drug Design Targeting Abl Kinase: How Structure and Regulation Can Assist in Designing New Drugs

  2024cites this paper
• Neuroprotective Activity of a Non-Covalent Imatinib+TP10 Conjugate in HT-22 Neuronal Cells In Vitro

  2024cites this paper
• Advancements and Future Prospects in Molecular Targeted and siRNA Therapies for Chronic Myeloid Leukemia

  2024cites this paper
• Compound Mutations in the Abl1 Kinase Cause Inhibitor Resistance by Shifting DFG Flip Mechanisms and Relative State Populations

  2024cites this paper
• Tyrosine Kinase Inhibitors in Cancers: treatment optimization - Part I.

  2024cites this paper
• Sub-Nanomolar Detection of Oligonucleotides Using Molecular Beacons Immobilized on Lightguiding Nanowires

  2024cites this paper
• Glutamate Receptors and C-ABL Inhibitors: A New Therapeutic Approach for Parkinson's Disease.

  2024cites this paper
• Validation of Endogenous Control Genes by Real-Time Quantitative Reverse Transcriptase Polymerase Chain Reaction for Acute Leukemia Gene Expression Studies

  2024cites this paper
• Elucidating cellular response to treatment with viral immunotherapies in pediatric high-grade glioma and medulloblastoma

  2024cites this paper
• Single-Cell Plasmonic Immunosandwich Assay Reveals the Modulation of Nucleocytoplasmic Localization Fluctuation of ABL1 on Cell Migration.

  2023cites this paper
• USP7 promotes non‐small‐cell lung cancer cell glycolysis and survival by stabilizing and activating c‐Abl

  2023cites this paper
• Thyroid function and opium use disorder: a cross-sectional study on the Fasa adults cohort study (FACS), 2017

  2023cites this paper
• c-Abl Phosphorylates MFN2 to Regulate Mitochondrial Morphology in Cells under Endoplasmic Reticulum and Oxidative Stress, Impacting Cell Survival and Neurodegeneration

  2023cites this paper
• Discovery of conformationally constrained c-Abl inhibitors with potential neuroprotective effects against Parkinson's disease.

  2023cites this paper
• Transcriptomic analyses of rats exposed to chronic mild stress: Modulation by chronic treatment with the antipsychotic drug lurasidone.

  2023cites this paper
• Mapping the substrate landscape of protein phosphatase 2A catalytic subunit PPP2CA

  2023cites this paper
• The ABL-MYC axis controls WIPI1-enhanced autophagy in lifespan extension

  2023cites this paper
• N-substituting perturbation on the interaction affinity and recognition specificity between rheumatic immune-related Abl SH3 domain and its peptoid ligands.

  2023cites this paper
• Inhibition of Abelson Tyrosine-Protein Kinase 2 Suppresses the Development of Alcohol-Associated Liver Disease by Decreasing PPARgamma Expression

  2023cites this paper
• Control of Ph+ and additional chromosomal abnormalities in chronic myeloid leukemia by tyrosine kinase inhibitors

  2023cites this paper
• MEK1/2 regulate normal BCR and ABL1 tumor-suppressor functions to dictate ATO response in TKI-resistant Ph+ leukemia

  2023cites this paper
• Src stimulates Abl-dependent phosphorylation of the guanine exchange factor Net1A to promote its cytosolic localization and cell motility

  2023influential citation
• c-Abl tyrosine kinase down-regulation as target for memory improvement in Alzheimer’s disease

  2023cites this paper
• Emerging roles of tyrosine kinases in hepatic inflammatory diseases and therapeutic opportunities.

  2023cites this paper
• The S2 Subunit of Infectious Bronchitis Virus Affects Abl2-Mediated Syncytium Formation

  2023cites this paper
• STS-1 and STS-2, Multi-Enzyme Proteins Equipped to Mediate Protein–Protein Interactions

  2023cites this paper
• The Potential of Cylindromatosis (CYLD) as a Therapeutic Target in Oxidative Stress-Associated Pathologies: A Comprehensive Evaluation

  2023cites this paper
• ABL kinases regulate the stabilization of HIF-1α and MYC through CPSF1

  2023cites this paper
• IQGAP1 Is a Phosphotyrosine-Regulated Scaffold for SH2-Containing Proteins

  2023cites this paper
• c-Abl Tyrosine Kinase Is Required for BDNF-Induced Dendritic Branching and Growth

  2023cites this paper
• c-Abl kinase-mediated phosphorylation of γ-tubulin promotes γ-tubulin ring complexes assembly and microtubule nucleation

  2022cites this paper
• Computational Identification of BCR-ABL Oncogenic Signaling as a Candidate Target of Withaferin A and Withanone

  2022cites this paper
• Efficient Interrogation of the Kinetic Barriers Demarcating Catalytic States of a Tyrosine Kinase with Optimal Physical Descriptors and Mixture Models.

  2022cites this paper
• Pharmacogenomics Driving Precision Cancer Medicine

  2022cites this paper
• Non-Coding RNAs Are Implicit in Chronic Myeloid Leukemia Therapy Resistance

  2022cites this paper
• Are off-target effects of imatinib the key to improving beta-cell function in diabetes?

  2022cites this paper
• Mechano‐cytoskeleton remodeling mechanism and molecular docking studies on nanosurface technology: Titania nanotube arrays

  2022cites this paper
• Putative COVID-19 therapies imatinib, lopinavir, ritonavir, and ivermectin cause hair cell damage: A targeted screen in the zebrafish lateral line

  2022cites this paper
• Genotoxicity-Stimulated and CYLD-Driven Malignant Transformation

  2022cites this paper
• The Abl/Abi signaling links WAVE regulatory complex to Cbl E3 ubiquitin ligase and is essential for breast cancer cell metastasis

  2022cites this paper
• Abelson tyrosine kinase controls BCR signalling and B‐cell differentiation by promoting B‐cell metabolism

  2022cites this paper
• A new strategy for the rapid identification and validation of direct toxicity targets of psoralen-induced hepatotoxicity.

  2022cites this paper
• Glucocorticoids Preferentially Influence Expression of Nucleoskeletal Actin Network and Cell Adhesive Proteins in Human Trabecular Meshwork Cells

  2022cites this paper
• c-Abl Activation Linked to Autophagy-Lysosomal Dysfunction Contributes to Neurological Impairment in Niemann-Pick Type A Disease

  2022influential citation
• Myristoyl’s dual role in allosterically regulating and localizing Abl kinase

  2022cites this paper
• Protein tyrosine kinase Abl promotes hepatitis C virus particle assembly via interaction with viral substrate activator NS5A

  2022cites this paper
• VNTR polymorphism in the breakpoint region of ABL1 and susceptibility to bladder cancer

  2021cites this paper
• Dasatinib in the Management of Pediatric Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

  2021cites this paper
• Target spectrum of the BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia

  2021cites this paper
• c-Abl Kinase Is Required for Satellite Cell Function Through Pax7 Regulation

  2021cites this paper
• Chronic Myeloid Leukemia

  2021cites this paper
• c-Abl activates RIPK3 signaling in Gaucher disease.

  2021cites this paper
• Chronic myeloid leukemia stem cells: targeting therapeutic implications

  2021cites this paper
• Discovery of Spiro-azaindoline Inhibitors of Hematopoietic Progenitor Kinase 1 (HPK1).

  2021cites this paper
• Inhibitors of Src Family Kinases, Inducible Nitric Oxide Synthase, and NADPH Oxidase as Potential CNS Drug Targets for Neurological Diseases

  2021cites this paper
• Parkinson's Disease Modification Through Abl Kinase Inhibition: An Opportunity

  2021cites this paper
• Molecular modeling piloted analysis for semicarbazone derivative of curcumin as a potent Abl-kinase inhibitor targeting colon cancer

  2021cites this paper
• Mesangioproliferative Kidney Diseases and Platelet-Derived Growth Factor–Mediated AXL Phosphorylation

  2021cites this paper
• Parkin interacting substrate phosphorylation by c-Abl drives dopaminergic neurodegeneration.

  2021cites this paper
• Cancer non-stem cells as a potent regulator of tumor microenvironment: a lesson from chronic myeloid leukemia

  2021cites this paper
• c-Abl Regulates a Synaptic Plasticity-related Transcriptional Program Involved in Memory and Learning.

  2021cites this paper
• Molecular insights on ABL kinase activation using tree-based machine learning models and molecular docking

  2021cites this paper
• Notch-dependent Abl signaling regulates cell motility during ommatidial rotation in Drosophila

  2021influential citation
• Role of the ABL tyrosine kinases in the epithelial–mesenchymal transition and the metastatic cascade

  2021cites this paper
• Recurrent Fusion of the GRB2 Associated Binding Protein 1 (GAB1) Gene With ABL Proto-oncogene 1 (ABL1) in Benign Pediatric Soft Tissue Tumors

  2020cites this paper
• Chronic Myeloid Leukemia

  2020cites this paper
• HDAC6—An Emerging Target Against Chronic Myeloid Leukemia?

  2020cites this paper
• Secondary Resistant Mutations to Small Molecule Inhibitors in Cancer Cells

  2020cites this paper
• The first quarter of the C-terminal domain of Abelson regulates the WAVE regulatory complex and Enabled in axon guidance

  2020cites this paper
• The N-terminal domain of the non-receptor tyrosine kinase ABL confers protein instability and suppresses tumorigenesis

  2020influential citation
• Simulations Studies of Protein Kinases that are Molecular Targets in Cancer

  2020cites this paper
• Abl1 deletion in gut stem cells suppresses p53 induction and promotes colitis-associated tumor formation

  2020cites this paper
• ABL1-dependent OTULIN phosphorylation promotes genotoxic Wnt/β-catenin activation to enhance drug resistance in breast cancers

  2020cites this paper
• NHD2-15, a novel antagonist of Growth Factor Receptor-Bound Protein-2 (GRB2), inhibits leukemic proliferation

  2020cites this paper
• Bimodal evolution of Src and Abl kinase substrate specificity revealed using mammalian cell extract as substrate pool

  2020cites this paper
• Ponatinib and other CML Tyrosine Kinase Inhibitors in Thrombosis

  2020cites this paper
• The COVID-19 pandemic: a global health crisis

  2020cites this paper
• Computational and Biological Investigations on Abl1 Tyrosine Kinase: A Review.

  2020cites this paper
• TPEN exerts selective anti-leukemic efficacy in ex vivo drug-resistant childhood acute leukemia

  2020cites this paper
• On Generation and Function of Neutrophil Extracellular Traps in Abdominal Sepsis

  2020cites this paper
• c-Abl Inhibition Activates TFEB and Promotes Cellular Clearance in a Lysosomal Disorder

  2020cites this paper